5 November 2018 in Journal of Asthma
Background: In the past few years, growing evidence supports a preventive role of vitamin D supplementation during pregnancy for wheezing or asthma in offspring. However, the optimal dose of vitamin D intake is unclear. We conducted a meta-analysis to examine the linear and nonlinear dose-response pattern of vitamin D intake during pregnancy and asthma or wheezing in offspring. Questions/purposes: The purpose of this study was to answer the following question: Which dose of vitamin D is more effective in preventing wheezing in offspring? Method: We identified relevant studies by searching PubMed, EMBASE and CENTRAL up to December 2017 and by hand-searching reference lists. Meta-analysis and subgroup analysis were performed. Fixed or random effects model linear trends analyses were conducted based on the heterogeneity test. Then, if the data did not show linear trends, we considered a nonlinear trend analysis instead. Results: A total of 6068 participants were included in the study. Our analysis showed an inverse relationship between the intake of vitamin D during pregnancy and the occurrence of wheezing in offspring (pooled OR = 0.68, 95% CI = 0.55-0.83, I2 = 24%, Z statistic = 3.64, p < 0.01). We found a nonlinear U-shaped association between vitamin D supplementation during pregnancy and asthma or wheezing in offspring, with the lowest risk at approximately 800 IU/d. Publication bias was shown in a funnel plot without Egger's test. Conclusions: Vitamin D intake during pregnancy is inversely related to wheezing or asthma in offspring. Furthermore, the trend analysis indicates that offspring may benefit from approximately 800 IU/d vitamin D intake during pregnancy.
14 August 2026 in Medicine
The diagnosis and monitoring of malignant respiratory diseases are heavily reliant on imaging techniques and tissue biopsies. Confocal laser endomicroscopy (CLE) is an advanced real-time imaging modality with high resolution, capable of visualizing the morphology and structure of pulmonary tissue in conjunction with conventional bronchoscopy. Within the realm of malignant respiratory diseases, it enables differentiation between normal and abnormal regions in the central airways, lung parenchyma, mediastinal lymph nodes, and pleura. Although CLE has not yet been integrated into routine clinical practice, it has the potential to guide biopsies, thereby enhancing diagnostic yield while mitigating the occurrence of associated complications. Moreover, this technology holds significant potential for elucidating disease pathogenesis, facilitating intraoperative assessment, and monitoring therapeutic efficacy. Looking towards the future, the integration of CLE with artificial intelligence represents a promising direction for the development of this technology. This review encapsulates the latest advancements of CLE in the context of malignant respiratory diseases, with a particular emphasis on its application in the diagnosis and treatment of lung cancer.